Neda K./LinkedIn
Apr 23, 2026, 16:55
Neda K.: When to Hold Antithrombotics and Use Bridging Therapy in Surgery
Neda K., Clinical Pharmacist, shared a post on LinkedIn:
”Perioperative Management of Antithrombotic: When to Hold Therapy
Perioperative management of antithrombotic therapy is all about balancing bleeding and thrombotic risks. The holding times for each agent are outlined in the image below.
Bridging Therapy: Who Really Needs It?
Indications for bridging when interrupting vitamin K antagonists:
Consider only in high thrombotic risk, such as:
- Mechanical heart valves
- Recent venous thromboembolism (VTE) (less than 3 months)
- Very high-risk atrial fibrillation
How to bridge?
- Discontinue warfarin 5 days before surgery.
- Start LMWH or UFH at therapeutic doses 3 days before surgery.
- Discontinue LMWH 24 hours or UFH 4 to 6 hours before surgery.”
Stay updated with Hemostasis Today.
-
Jun 23, 2026, 23:30Shunsuke Iwano: PMDA Introduces Greater Flexibility for Pediatric Factor VIII and IX Development in Japan
-
Jun 23, 2026, 23:05Rounak Dubey: ISBT Academy Session on Agentic AI
-
Jun 23, 2026, 22:59Mohammed Maher Babiker: When ‘Low Platelets’ aren’t Really Low
-
Jun 23, 2026, 22:49Giovanni Merlino: Why Does Stress Hyperglycemia Worsen Stroke Outcomes?
-
Jun 23, 2026, 22:41Tareq Abadl: Coombs Test – The Key to Detecting Immune-Mediated Hemolysis
-
Jun 23, 2026, 22:32How WFH Impacted the Bleeding Disorders Community in 2025
-
Jun 23, 2026, 22:03Erin VanDyke: A Journey Through VTE Leadership and Healthcare Transformation
-
Jun 23, 2026, 21:19Ahmed Koriesh: Join Us for Future of Stroke Care 2026
-
Jun 23, 2026, 20:30Aladdin Mohammad: Baseline IgG as a Key Predictor of Hypogammaglobulinaemia in AAV